PEMF therapy is not shown to work for tinnitus: of two small placebo-controlled trials, the one using standard tinnitus questionnaires found no benefit over placebo, and the positive one rested on a one-week, four-category self-rating.
Pulsed electromagnetic field (PEMF) therapy is a different technology from TMS, which is more rigorously studied for tinnitus. It is broadly marketed, and the controlled evidence for tinnitus specifically is thinner and more mixed than either its sellers or its critics tend to say.
What PEMF is
PEMF devices generate electromagnetic pulses, applied to the body (or, for tinnitus, near the head or ear) on the general theory that they can influence cellular processes including inflammation, blood flow, and nerve function. It is a different mechanism from TMS, which uses more targeted, higher-intensity magnetic pulses to modulate activity in identified brain regions.
One of the devices tested for tinnitus, Diapulse, shows how widely these machines are applied: an insurer's policy review, last reviewed in June 2026, lists its use for chronic wounds, soft tissue injuries, migraine, tinnitus, acute head injuries and pelvic inflammatory disease.
The two placebo-controlled trials
1993: positive, on a simple measure. A pilot trial in Clinical Otolaryngology and Allied Sciences recruited 58 volunteers from a tinnitus association in Liverpool. Active and placebo devices, applying pulsed electromagnetic stimulation over the mastoid bone behind the ear, were randomly allocated and the trial was double-blind. After one week of treatment, each patient said whether their tinnitus had disappeared, improved, stayed the same or got worse. Among those who completed the trial, 45% improved with the active device against 9% with placebo (P = 0.0013). The authors suggested electromagnetic stimulation may be an effective treatment for some people with tinnitus.
2004: negative, on standard measures. A randomised, double-blind, placebo-controlled pilot study in The Laryngoscope used the Diapulse device, a high-frequency PEMF system set at 27.12 MHz and 600 pulses per second. The 37 adults, all with tinnitus of at least six months' duration, had 30-minute sessions three times weekly for one month, with real or placebo treatment. Before and after, they completed the Tinnitus Handicap Inventory and a tinnitus rating questionnaire and had hearing tests, including tinnitus pitch and loudness matching. Neither group changed significantly on the THI, the tinnitus ratings or hearing thresholds — not the real treatment group and not the placebo group — and the authors concluded that high-frequency PEMF, at the settings used, showed no role in treating chronic tinnitus.
How to weigh them
These are not two tries at the same thing. The devices, settings and treatment lengths differed, so the 2004 trial is not strictly a failed repeat of the 1993 one. But they are the controlled evidence there is: a PubMed search in September 2026 for tinnitus with pulsed electromagnetic terms turned up these two placebo-controlled trials and no others.
Between them, the weight falls on the 2004 trial. It treated people for a month rather than a week, and it measured tinnitus with a validated questionnaire and hearing tests rather than a single four-way rating straight after treatment — the kind of outcome most open to expectation. The 1993 abstract reports its result among those who completed the trial without saying how many did not. So the honest summary is that PEMF for tinnitus is unproven, and the better-measured evidence points to no benefit. Tinnitus also fluctuates and drifts on its own, which is why placebo-controlled designs matter so much here.
Newer reports, and why they do not change that
A 2005 study in the International Tinnitus Journal reported that pulsed magnetic-field therapy changed brainwave patterns on EEG, changes its authors linked to a decrease in tinnitus symptoms.
A 2024 study at a university hospital in Rome gave 55 patients a portable device combining personalised sound therapy with low- and high-frequency electromagnetic stimulation. For the first two weeks it delivered sound therapy only, with no significant change in Tinnitus Functional Index scores; then the electromagnetic stimulation was added for two one-month cycles. By the end, 73% had improved on the index, and 39% by 13 points or more. The authors state the limits plainly: there was no external control group and no sham stimulation, and the design cannot separate the effects of the sound therapy from the electromagnetic stimulation. Like other sequential designs, it also cannot separate the added stimulation from the passing of time.
Both are reasons to run a proper trial. Neither is evidence that PEMF works for tinnitus. Reading a tinnitus study sets out the patterns that make results like these look stronger than they are.
What this means for marketed PEMF devices
PEMF devices are marketed for a wide range of conditions well beyond tinnitus, and evidence quality varies by condition. Broad marketing does not transfer evidence from one condition to another: for tinnitus, the controlled trial using standard measures found no benefit over placebo.
What this means practically
- The better-measured controlled trial found no benefit over placebo. The positive one was shorter and used a much simpler outcome.
- If a PEMF device or clinic cites positive studies, ask whether they had a placebo group, how long treatment lasted, and what was measured. Several of the positive reports had no control group at all.
- This does not mean PEMF is dangerous — the studies report no harm — but spending money on it for tinnitus is not supported by the stronger evidence.
- Treatments with stronger controlled evidence — sound therapy, CBT, and hearing aids where there is hearing loss — remain the better-supported places to start.
A note on what this page used to say
An earlier version of this page described the 2004 trial as the only controlled evidence for PEMF in tinnitus, and the positive reports as older studies without a placebo group. That was wrong: a 1993 double-blind, placebo-controlled trial had reported a benefit. It is now described above, together with the reasons its result carries less weight than the 2004 trial's. The overall reading — that PEMF for tinnitus is unproven — did not change.